In this podcast, we spoke with the CEO and founder of Supersapiens, the company that is on a mission to use real-time glucose insights to shape the future of human performance.
Phil discusses his personal motivations for starting Supersapiens as a Type1 diabetic and his love for entrepreneurship. He also gave us exclusive insights into the company's long-time partnership with Abbott and how the American medical company has built a unique real-time streaming sensor for its use case.
Moreover, Phil talks about the power of referrals and how this led him to work with powerful sports organizations such as the Atlanta Falcons (NFL), the New York Yankees (MLB), team Ineos Grenadiers (Tour de France), and the San Antonio Spurs (NBA).
Lastly, the conversation centers around the future of wearable sensors and continuous glucose monitors.
Supersapiens ►
LinkedIn ►
Twitter ► @supersapiensinc
--
TERRA ►
More Podcasts ►
Twitter ►
LinkedIn ►
--
00:00 - Intro
01:09 - What is Supersapiens
07:07 - The evolution of continuous glucose monitors (CGMs)
14:31 - Phil's personal motivation to starting Supersapiens
19:53 - The first athletes adopting the product - elite cycling teams
22:30 - Partnership with Abbott and real-time streaming sensor
23:33 - The first product they built - MVP
26:17 - Working closely with elite athletes and metabolic response to stress
33:25 - Phil's approach to fundraising and investors - the power of referrals
44:15 - Advice for pitching to investors - insights from Eric Min and Chip Hawkins
49:38 - The future of sensors and partnership with Terra